JPWO2021246200A1 - - Google Patents

Info

Publication number
JPWO2021246200A1
JPWO2021246200A1 JP2022528744A JP2022528744A JPWO2021246200A1 JP WO2021246200 A1 JPWO2021246200 A1 JP WO2021246200A1 JP 2022528744 A JP2022528744 A JP 2022528744A JP 2022528744 A JP2022528744 A JP 2022528744A JP WO2021246200 A1 JPWO2021246200 A1 JP WO2021246200A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022528744A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021246200A1 publication Critical patent/JPWO2021246200A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
JP2022528744A 2020-06-02 2021-05-21 Pending JPWO2021246200A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020095925 2020-06-02
JP2021012033 2021-01-28
PCT/JP2021/019349 WO2021246200A1 (en) 2020-06-02 2021-05-21 Muscle atrophy suppressing agent

Publications (1)

Publication Number Publication Date
JPWO2021246200A1 true JPWO2021246200A1 (en) 2021-12-09

Family

ID=78830995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528744A Pending JPWO2021246200A1 (en) 2020-06-02 2021-05-21

Country Status (3)

Country Link
JP (1) JPWO2021246200A1 (en)
CN (1) CN115768417A (en)
WO (1) WO2021246200A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023243210A1 (en) * 2022-06-13 2023-12-21 丸善製薬株式会社 Myoblast proliferation promoting agent, composition for promoting myoblast proliferation, muscular atrophy inhibiting agent, and composition for inhibiting muscular atrophy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112819A1 (en) * 2003-06-13 2004-12-29 Gelstat Corporation Compositions and methods of treatment comprising plant extracts
JP2005194246A (en) * 2004-01-09 2005-07-21 Ichimaru Pharcos Co Ltd NF-kappaB ACTIVATION INHIBITOR
JP2006206532A (en) * 2005-01-31 2006-08-10 Ichimaru Pharcos Co Ltd NF-kappaB ACTIVATION INHIBITOR
EP2001455A2 (en) * 2006-03-15 2008-12-17 Theralogics, Inc. Methods of treating muscular wasting diseases using nf-kb activation inhibitors
EP2661266B1 (en) * 2011-01-07 2020-09-16 Anji Pharma (US) LLC Chemosensory receptor ligand-based therapies
CN103641841A (en) * 2013-12-10 2014-03-19 上海市第六人民医院 Sesquiterpene lactone compounds as well as preparation method and application thereof
JP2020040884A (en) * 2018-09-06 2020-03-19 三基商事株式会社 Anti-fatigue composition by activation of energy metabolism in muscle cell containing artichoke leaf extract or cynaropicrin

Also Published As

Publication number Publication date
CN115768417A (en) 2023-03-07
WO2021246200A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
BR112021014123A2 (en)
BR112023012656A2 (en)
BR112022024743A2 (en)
BR102021018859A2 (en)
BR112022009896A2 (en)
BR102021007058A2 (en)
BR102020022030A2 (en)
JPWO2023127911A1 (en)
BR112023016292A2 (en)
BR112023004146A2 (en)
BR102021020147A2 (en)
BR102021018926A2 (en)
BR102021016837A2 (en)
BR102021016176A2 (en)
BR102021015566A2 (en)
BR102021015450A8 (en)
BR102021015500A2 (en)
BR102021015247A2 (en)
BR102021015220A2 (en)
BR102021014056A2 (en)
BR102021014044A2 (en)
BR102021013929A2 (en)
BR112021017747A2 (en)
BR102021012571A2 (en)
BR102021012230A2 (en)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231120

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240416